Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Non-Current Assets (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Non-Current Assets for 5 consecutive years, with $915000.0 as the latest value for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 87.28% year-over-year to $915000.0; the TTM value through Dec 2025 reached $13.5 million, down 66.84%, while the annual FY2025 figure was $915000.0, 87.28% down from the prior year.
  • Non-Current Assets hit $915000.0 in Q4 2025 for Kezar Life Sciences, down from $3.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $19.9 million in Q2 2023 and bottomed at $915000.0 in Q4 2025.
  • Average Non-Current Assets over 5 years is $9.2 million, with a median of $6.5 million recorded in 2021.
  • Year-over-year, Non-Current Assets surged 222.78% in 2023 and then plummeted 87.28% in 2025.
  • Kezar Life Sciences' Non-Current Assets stood at $6.3 million in 2021, then soared by 120.51% to $13.8 million in 2022, then rose by 3.17% to $14.3 million in 2023, then crashed by 49.64% to $7.2 million in 2024, then plummeted by 87.28% to $915000.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $915000.0, $3.2 million, and $4.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.